Bafna Pharmaceuticals IPO, Review, IPO Performance by IPOPlatform India

About Bafna Pharmaceuticals

Company Information

Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand under the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactam and Non-Betalactam products. The first manufacturing unit was set up at Madhavaram in October 1984 for the production of tablets, with an installed capacity of 420 lacs tablets per annum. Subsequently, the capsule line was added in 1987, with a capacity of 300 lacs capsules per annum, and then the liquid line was introduced in 1990, with an installed capacity of 45,000 liters per annum.

In 1995, Bafna Pharmaceuticals Limited was incorporated and acquired the entire business of the proprietary concern. In 2001, the company constructed a separate block at Madhavaram

Object of Issue

To undertake Brand Building exercise in domestic & international markets
To part finance the cost of obtaining MHRA approval for Grantlyon unit
To set up a Research & Development unit at Grantlyon
To repay high cost debt
To meet the working capital requirement
To meet expenses of the Issue in order to achieve the benefits of listing on the Stock Exchanges
General corporate purposes

Bafna Pharmaceuticals MainBoard IPO Details (at the time of IPO)

IPO Type :

Fixed Price

IPO Date :

Jun, 2008

IPO Size :

25.60 Cr.

PE Multiple :

12.44

Merchant Banker :
Keynote Financial Services Limited

IPO Registrar:
Cameo Corporate Services Limited

FAQs

1. What is Bafna Pharmaceuticals IPO?

Bafna Pharmaceuticals operates in Pharmaceutical and Pharmaceutical. The Issue is listed on MainBoard in Jun, 2008. Bafna Pharmaceuticals IPO size was 25.60 Cr. with Issue price of 40.00 .

2. Who is the merchant banker of Bafna Pharmaceuticals IPO?

Merchant Banker(s) of Bafna Pharmaceuticals IPO: Keynote Financial Services Limited , Ashika Capital Limited

3. How many times Bafna Pharmaceuticals IPO was subscribed?

Bafna Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

4. What is the listing price of Bafna Pharmaceuticals IPO?

Bafna Pharmaceuticals IPO listed at a listing price of 38.50 against the offer price of 40.00.

5. What is the current market price of Bafna Pharmaceuticals IPO?

The current market price of Bafna Pharmaceuticals is .